Digene Wins Arbitration Ruling Over HPV License
Digene Corp., a manufacturer of genetic-testing products, said Monday that an arbitration panel found that a rival breached a cross-licensing agreement covering the sale of its human papillomavirus (HPV) business....To view the full article, register now.
Already a subscriber? Click here to view full article